𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Analysis of the BRAFV600E Mutation in Central Nervous System Tumors

✍ Scribed by Kyung Myung, Jae; Cho, Hwajin; Park, Chul-Kee; Kim, Seung-Ki; Lee, Se-Hoon; Park, Sung-Hye


Book ID
122304043
Publisher
Elsevier
Year
2012
Tongue
English
Weight
463 KB
Volume
5
Category
Article
ISSN
1936-5233

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Dual priming oligonucleotide–based multi
✍ Jin Young Kwak; Eun-Kyung Kim; Jong-Kee Kim; Jeong-Hyun Han; Soon Won Hong; Tae 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB

## Abstract ## Background. To evaluate the diagnostic value of dual priming oligonucleotide (DPO)–based multiplex polymerase chain reaction (PCR) for the detection of BRAF^V600E^ mutations in ultrasound‐guided fine‐needle aspiration biopsy (US‐FNAB) of thyroid nodules. ## Methods. Our institutio

Mutation analysis and loss of heterozygo
✍ Irene Slavc; Ignacio R. Rodriguez; Krzysztof Mazuruk; Gerald J. Chader; Jaclyn A 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 120 KB 👁 2 views

Deletion of 17p is the most frequent abnormality observed in central nervous system (CNS) primitive neuroectodermal tumors (PNETs), implicating the presence of a tumor suppressor gene which maps to 17p. The gene for pigment epitheliumderived factor (PEDF) has been cloned and mapped to 17p13. PEDF be

Optimizing targeted therapeutic developm
✍ Jeanne Tie; Peter Gibbs; Lara Lipton; Michael Christie; Robert N. Jorissen; Anto 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 387 KB 👁 1 views

## Abstract BRAF^__V600E__^ mutations are found in 10% of colorectal cancers (CRCs). The low frequency of this mutation therefore makes it a challenging target for drug development, unless subsets of patients with higher rates of BRAF^__V600E__^ can be defined. Knowledge of the concordance between